Ontvang nu dagelijks onze kooptips!

word abonnee
IEX 25 jaar
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
Markt vandaag Koersen Forum Premium IEX Expert
Home  /   Forum   /   Sopheon   /   Sopheon maart 2021

Sopheon« Terug naar discussie overzicht

Sopheon maart 2021

Volgen
55 Posts
Pagina: «« 1 2 3 »» | Laatste | Omlaag ↓
  12. [verwijderd] 24 maart 2021 08:28
    Zoals jullie weten ,heb ik het geluk gehad om al mijn aandelen in Sopheon te verkopen rond hun ATH. Op dat moment vond ik the K/W verhouding niet meer in verhouding staan t.o.v hun groei!
    Ben ook Noot meer ingestapt ook niet op 5,
    Mijn mening is dat Sopheon een goed bedrijf is, aangezien the omstandigheden van, zeg de laatste 15 maanden.. Ze maken ongeveer de zelfde winst als vorige jaar.( Cijfers zijn net uit) Maar het dividend rendement is te laag om in te stappen.
    Naar mijn mening doen ze te weinig met hun excellent gevulde kas! Dus in mijn ogen zijn er 1 reden om weer in te stappen, als ze een overname doen wat de groei weer aanzwengelt. Aangezien ik dit al jaren verwachtt en gebeurt niet , daarbij de aandelen verkoop op 9 euro doen mij niet hoopgevend stemmen.
    Het beste voor de huidige aandeelhouders zou een overname zijn! Maar dan ben ik te laat!

    Conclusie voor mij; dood geld voor te time being en alleen een overname door Sopheon zou mijn interesse weer wekken.
    Voor jullie een overname van Sopheon.

    Suc6 allemaal .

    Groet trinko
  13. Bertus S 24 maart 2021 09:01
    Hier nog even de samenvatting:

    Audited Results Statement for the Year to 31 December 2020

    Sopheon plc, the international provider of software, expertise, and best practices for Enterprise Innovation Performance, is pleased to announce its results for the year ended 31 December 2020, in line with market expectations, together with an outlook for the current year.

    Financial Highlights:

    Revenue of $30.0m, maintained in the face of challenging year due to COVID, whilst embarking on a SaaS transition (2019: $30.3m)
    ARR1 rose from $15.9m at the start of 2020 to $18.0m at the end of the year
    Full year 2021 revenue visibility2 is now at $24.5m (last year at this time: $21.2m)
    TCV2 of signed contract bookings up 1.25X, and TCV of SaaS bookings up 2.74X
    Adjusted EBITDA3 of $5.9m (2019: $6.4m)
    PBT of $1.7m (2019: $2.5m)
    Net cash of $21.7m (2019: $19.4m) and the Group has no debt
    Dividend to be maintained at 3.25p per share (2019: 3.25p)

    Operational Highlights

    10 new customer wins including DuPont, LG, Hochland, Clif Bar and Mondelez. Six of the new customers signed had deal values over $1m.
    SaaS First and SaaS uplift programs introduced to assist clients in moving to the cloud. Over 50% of new clients signed SaaS contracts and four existing clients converted to SaaS as part of the SaaS Uplift program.
    Continued investment in cloud-native SaaS capabilities for Accolade
    Gross retention of 91.5% (2019: 94.2%) with customers taking cost decisions earlier in the year, with a return to improved levels in the second half
    Greg Coticchia, who has been working with us for some time and demonstrated his capability and value add to the Group, to join Board and spearhead cloud strategy as CEO. Andy Michuda to become Executive Chairman, focusing on partnerships and M&A alongside governance. Barry Mence to step down to become a Non-Executive Director.

    Barry Mence, Chairman, commented: “With a solid revenue base already in place for 2021, plus our strong balance sheet, a superb customer base and a team of great people – I am confident that Sopheon has a great future, and that the SaaS transition is exactly the right strategy to pursue. The board is excited to be appointing Greg Coticchia as CEO – he is already having significant impact on the business, and his experience and track record in software and innovation are invaluable. I can think of no better person than Andy Michuda for the role of Executive Chairman. My own commitment to Sopheon is undimmed, and I will remain a non-executive director and major shareholder in the company as we go through this exciting new chapter in the Sopheon story. We also continue to believe in sharing success with shareholders, and I am therefore pleased to announce that we will again maintain our dividend at 3.25p per share.”

    For further information contact:

    Barry Mence (Chairman)
    Arif Karimjee (CFO) Sopheon plc + 44 (0) 1276 919 560

    Bertus S.
  20. [verwijderd] 24 maart 2021 15:08
    Sopheon Names Greg Coticchia Chief Executive Officer
    Experienced Tech Leader to Drive Growth of Sopheon’s SaaS-based Enterprise Innovation Management Platform

    MINNEAPOLIS –March 24, 2021 – Sopheon (LSE: SPE) today announced the appointment of Greg Coticchia to the position of Chief Executive Officer (CEO), effective on March 31, 2021. As part of this planned transition strategy, Andy Michuda will become Executive Chairman of Sopheon’s Board of Directors. Barry Mence, who has been Chairman of the Board since the company’s inception, will serve as a non-executive director of Sopheon and remain a major investor in the company.

    Coticchia, who joined Sopheon as President in 2020, will also take a seat on the board of directors. With deep experience in the creation and growth of SaaS companies, Coticchia is an award-winning entrepreneur, business strategist, product manager and marketing expert.

    Coticchia will spearhead Sopheon’s growth as the industry’s most versatile and powerful enterprise innovation management cloud platform. Michuda will focus on partnerships and acquisitions, in addition to his governance responsibilities as Executive Chairman.

    “Digital transformation continues to accelerate, and innovation is an urgent imperative for virtually every company,” said Coticchia. “But fostering and governing innovation can be difficult in large organizations with diverse methodologies and siloed teams. Sopheon has a large opportunity to build upon its success at hundreds of companies worldwide to drive— and keep—innovation moving forward aggressively while still delivering resilient and reliable product experiences."

    “We welcome Greg to Sopheon’s board of directors and look forward to his creative and energetic leadership as CEO,” said Mence, a co-founder of Sopheon. “Greg is a highly-regarded entrepreneur, business leader, professor and author. His impressive experience in leading strategic transitions in the SaaS industry is an ideal fit as we continue to grow our popular SaaS-based offerings.”

    Accolade is Sopheon’s innovation management platform. Accolade enables businesses to operate with more agility and responsiveness. By creating cross-functional collaboration and synchronization, Accolade connects people, systems and information across departments and functions. This results in faster time to market, increased product success and reduced costs.

    Accolade has proven its value to thousands of global users, such as PepsiCo, P&G, Merck KgaA, Mondelez, BASF, Parker Hannifin and other innovation and market leaders across a wide variety of industries.

    For more information about how Sopheon is transforming enterprise innovation, visit our website at www.sopheon.com.

    Sopheon released financial results for 2020 earlier today. The annual report can be viewed at www.sopheon.com/financial-reports.
55 Posts
Pagina: «« 1 2 3 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Markt Vandaag

Stijgers

instrument koers absoluut verschil relatief verschil
IMCD 152,900 +8,60 +5,96%
Aperam 27,360 +1,42 +5,47%
HEIJMANS KON 26,200 +1,10 +4,38%
UMG 23,710 +0,46 +1,98%
SBM Offshore 17,810 +0,28 +1,60%
RELX 44,640 +0,66 +1,50%
NSI 19,740 +0,26 +1,33%
Eurocommercial Properties 23,450 +0,30 +1,30%
CTP 14,700 +0,18 +1,24%
Ahold Delhaize 32,390 +0,34 +1,06%
WDP 21,200 +0,22 +1,05%
JUST EAT TAKEAWAY 11,295 +0,12 +1,03%
Vopak 43,080 +0,42 +0,98%
TKH 36,500 +0,32 +0,88%
Wolters Kluwer 161,850 +1,40 +0,87%
AMG Critical Materials N.V. 15,210 +0,13 +0,86%
Wereldhave 14,180 +0,12 +0,85%
Fagron 18,960 +0,16 +0,85%
KPN 3,618 +0,03 +0,81%
BESI 109,500 +0,70 +0,64%
JDE PEET'S 18,850 +0,07 +0,37%
Nedap N.V. 54,800 +0,20 +0,37%
Basic-Fit 22,820 +0,08 +0,35%
ACOMO 17,360 +0,04 +0,23%
BAM 4,160 +0,01 +0,19%
DSM FIRMENICH AG 104,800 +0,05 +0,05%
ING 14,990 +0,01 +0,04%
AZERION 1,296 0,00 0,00%
B&S Group SA 4,500 0,00 0,00%
Kendrion 11,000 0,00 0,00%
Vastned 24,500 0,00 0,00%

Dalers

instrument koers absoluut verschil relatief verschil
Alfen N.V. 11,700 -1,85 -13,65%
EBUSCO HOLDING 3,390 -0,46 -11,96%
ADYEN NV 1.272,600 -63,20 -4,73%
RANDSTAD NV 42,000 -1,52 -3,49%
INPOST 17,480 -0,47 -2,62%
Pharming 0,738 -0,02 -2,57%
PROSUS 38,440 -1,02 -2,57%
Fugro 16,760 -0,44 -2,56%
Philips Koninklijke 24,870 -0,63 -2,47%
Avantium 2,200 -0,05 -2,44%
Accsys 0,590 -0,01 -2,32%
THEON INTERNAT 8,980 -0,21 -2,29%
CM.COM 6,250 -0,13 -2,04%
FASTNED 21,800 -0,45 -2,02%
Air France-KLM 7,780 -0,16 -2,02%
Brunel 8,780 -0,18 -2,01%
ArcelorMittal 24,140 -0,49 -1,99%
Sif Holding 13,140 -0,24 -1,79%
Galapagos 25,120 -0,42 -1,64%
SIGNIFY NV 21,680 -0,36 -1,63%
Aegon 6,144 -0,09 -1,48%
NX FILTRATION 4,540 -0,07 -1,41%
ALLFUNDS GROUP 5,500 -0,07 -1,26%
PostNL 1,001 -0,01 -1,18%
SHELL PLC 31,250 -0,36 -1,15%
Akzo Nobel 58,820 -0,58 -0,98%
Corbion 22,360 -0,22 -0,97%
EXOR NV 94,650 -0,90 -0,94%
ASR Nederland 44,870 -0,32 -0,71%
ABN AMRO BANK N.V. 15,220 -0,10 -0,69%
TomTom 5,245 -0,04 -0,66%
ASMI 508,800 -2,80 -0,55%
ASML 621,500 -3,20 -0,51%
AEX 874,18 -4,36 -0,50%
Heineken 72,580 -0,36 -0,49%
Flow Traders 21,500 -0,10 -0,46%
RENEWI 7,360 -0,03 -0,41%
OCI 10,700 -0,04 -0,33%
UNILEVER PLC 54,560 -0,14 -0,26%
NN Group 45,130 -0,10 -0,22%
Sligro 11,160 -0,02 -0,18%
AMX 867,36 -1,40 -0,16%
ForFarmers 3,415 0,00 -0,15%
Van Lanschot Kempen NV 41,800 -0,05 -0,12%
ASCX 1.198,78 -1,05 -0,09%
Arcadis 65,100 -0,05 -0,08%
AALBERTS NV 35,120 -0,02 -0,06%
vlag naam koers verschil relatief verschil
AEX 874,18 -4,36 -0,50%
AEX GR 3.422,93 -17,05 -0,50%
Germany40^ 19.238,10 -124,42 -0,64%
FTSE 100 8.072,39 -68,35 -0,84%
EURO50 4.814,83 0,00 0,00%
US30^ 44.011,10 0,00 0,00%
Nasd100^ 21.123,70 0,00 0,00%
US500^ 6.000,22 0,00 0,00%
Japan225^ 39.109,80 0,00 0,00%
VD-NEW 15,36 -0,09 -0,58%
#/^ Index indications calculated real time, zie disclaimer